Division of Vascular Surgery, Temple University School of Medicine, Philadelphia, Pa.
Division of Vascular Surgery, Temple University School of Medicine, Philadelphia, Pa.
J Vasc Surg. 2018 Jul;68(1):219-224. doi: 10.1016/j.jvs.2017.10.081. Epub 2018 Feb 3.
The standard of care in the treatment of vascular disease continues to evolve as endovascular therapies develop. Currently, it is unclear how medical malpractice litigation has adapted to the "endovascular era." This retrospective case review is the most comprehensive analysis to date of malpractice actions involving endovascular procedures performed by vascular surgeons (VSs), interventional radiologists (IRs), interventional cardiologists (ICs), and cardiothoracic surgeons (CTSs).
The legal databases LexisNexis and Westlaw were searched for all published legal cases in the United States involving endovascular procedures. The search was limited to state and federal cases up to and including the year 2016. Keywords included "malpractice," "vascular," "endovascular," "catheter," "catheterization," "stent," "angiogram," "angiography," and "surgery." Cases involving tax revenue, insurance disputes, Social Security Disability, and hospital employment contract disputes were excluded. Data were analyzed using χ test.
There were 2115 initial search results identified, and 369 cases were included in final analysis. The rate of endovascular procedure-related lawsuits (per 1000 active physicians in the specialty) was highest for ICs (105.56), whereas rates for VSs and IRs were comparable (18.47 and 16.85, respectively); 93% of the IC cases were related to coronary interventions. Overall, 55% (148/271 classifiable cases) of actions were related to elective procedures. For VSs specifically, 46% (25/54) of cases arose from diagnostic angiography and inferior vena cava filter placement, two relatively minor procedure types. Overall, 83% (176/211 finalized cases) of verdicts favored defendants, with no significant differences across the specialties; 43% (157/368) of total cases involved death of the patient. Among the four specialties, there was a significant (P = .0004) difference in the primary allegation (informed consent, preprocedure negligence, intraprocedure complications, or postprocedure complications) underlying the litigation. For CTSs and VSs, there was a predominance of informed consent and preprocedure negligence allegations (70% [7/10] and 52% [28/54], respectively). Intraprocedure negligence was the most common allegation for IRs (59% [23/39]), whereas allegations were more evenly distributed among ICs.
Key issues were identified regarding malpractice litigation involving the specialties that commonly perform endovascular procedures. Despite the increasing number of ICs doing peripheral interventions, a large majority of IC cases were related to coronary treatments. A surprisingly large percentage of VS cases were related to seemingly minor cases. There were significant interspecialty differences in the primary underlying allegations. As the scope of endovascular procedures broadens and deepens, it is important for clinicians to be aware of legal considerations relevant to their practice.
随着腔内治疗的发展,血管疾病治疗的护理标准不断发展。目前,尚不清楚医疗事故诉讼是如何适应“腔内时代”的。本回顾性病例研究是迄今为止对血管外科医生(VS)、介入放射科医生(IR)、介入心脏病学家(IC)和心胸外科医生(CTS)进行的腔内手术相关医疗事故行为进行的最全面分析。
在 LexisNexis 和 Westlaw 法律数据库中搜索了美国所有涉及腔内手术的已发表法律案例。搜索范围限于州和联邦案件,截至 2016 年。关键词包括“医疗事故”、“血管”、“腔内”、“导管”、“导管插入术”、“支架”、“血管造影”、“血管造影术”和“手术”。排除与税收、保险纠纷、社会保障残疾和医院就业合同纠纷有关的案件。使用 χ 检验对数据进行分析。
最初搜索结果有 2115 项,最终纳入 369 项分析。与腔内手术相关的诉讼率(每千名活跃医师)最高的是 IC(105.56),而 VS 和 IR 的比率相当(分别为 18.47 和 16.85);93%的 IC 病例与冠状动脉介入有关。总体而言,55%(148/271 可分类病例)的诉讼与择期手术有关。具体到 VS,46%(25/54)的病例来自诊断性血管造影和下腔静脉滤器放置,这两种手术类型相对较小。总体而言,83%(176/211 最终确定的病例)的判决有利于被告,各专业之间没有显著差异;43%(157/368)的总病例涉及患者死亡。在这四个专业中,诉讼的主要指控(知情同意、术前疏忽、术中并发症或术后并发症)存在显著差异(P =.0004)。对于 CTS 和 VS,知情同意和术前疏忽的指控居多(分别为 70%[7/10]和 52%[28/54])。术中疏忽是 IR 最常见的指控(59%[23/39]),而 IC 的指控分布更为均匀。
确定了与常见腔内手术专业相关的医疗事故诉讼的关键问题。尽管进行外周介入治疗的 IC 数量不断增加,但大多数 IC 病例仍与冠状动脉治疗有关。VS 病例中与看似较小的病例相关的比例惊人地高。主要潜在指控存在显著的专科间差异。随着腔内治疗范围的扩大和深化,临床医生了解与实践相关的法律考虑因素非常重要。